SCHEMBL16320313

SCHEMBL16320313

NSc1ccccc1Cc1cc(Br)cc(Br)c1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
TTR P02766 1/20 0.43
MEN1 O00255 6/20 0.42
KMT2A Q03164 6/20 0.42
MAPT P10636 4/20 0.42
POLB P06746 2/20 0.38
ALDH1A1 P00352 1/20 0.38
PLEC Q15149 1/20 0.38
CYP3A4 P08684 2/20 0.38
TSHR P16473 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA9 Q16790 2/20 0.38
CYP1A2 P05177 2/20 0.37
CYP2D6 P10635 2/20 0.37
CYP2C19 P33261 2/20 0.37
HIF1A Q16665 2/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL825071 0.79 HSPA5 (0.57) LMNATTRMEN1KMT2AMAPT
SCHEMBL67463 0.78 CYP3A4 (0.62) LMNATTRMEN1KMT2AMAPT
SCHEMBL16351512 0.76 CYP1A2 (0.45) LMNATTRMEN1KMT2AMAPT
SCHEMBL16341500 0.73 HSP90AA1 (0.62) LMNATTRMEN1KMT2AMAPT
SCHEMBL16320620 0.69 HSPA5 (0.45) MEN1KMT2AMAPTALDH1A1CYP3A4
SCHEMBL16320314 0.68 KMT2A (0.46) LMNATTRMEN1KMT2AMAPT
SCHEMBL14616155 0.67 CYP3A4 (0.56) LMNATTRMEN1KMT2AMAPT
SCHEMBL4814298 0.65 GFER (0.46) LMNATTRMEN1KMT2AMAPT
SCHEMBL18620124 0.65 APOBEC3G (0.38) LMNAMEN1KMT2AMAPTPOLB
SCHEMBL2120858 0.65 CYP3A4 (0.59) LMNATTRMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9150676-B2 Thio-salalen catalyst EXXONMOBIL CHEMICAL PATENTS INC. (US) 2015-10-06 US disclosed
US-20140378634-A1 Thio-Salalen Catalyst EXXONMOBIL CHEMICAL PATENTS INC. (US) 2014-12-25 US disclosed
WO-2014204624-A1 THIO-SALALEN CATALYST EXXONMOBIL CHEMICAL PATENTS INC. (US) 2014-12-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378634-A1 Thio-Salalen Catalyst TST, SPR, STS LMNA 4457/4885TTR 517/4885MEN1 3787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.